You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-18

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early Disease Onset Trial (Puva (psoralin and uva ))

Not yet recruiting
  • Early Disease Onset
  • Puva (psoralin and uva )
  • (no location specified)
Sep 27, 2023

NGAL, IL 18 as Predictors of Acute Kidney Injury in Renal

Completed
  • Kidney Transplant; Complications
  • Acute Kidney Injury
    • (no location specified)
    Oct 18, 2021

    Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

    Recruiting
    • Neuroblastoma Recurrent
    • Natural killer cell
    • +4 more
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Feb 22, 2023

    Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

    Active, not recruiting
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Aldesleukin
    • +6 more
    • Los Angeles, California
    • +3 more
    Nov 16, 2022

    Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

    Active, not recruiting
    • Malignant Neoplasm
    • aldesleukin
    • +7 more
    • Los Angeles, California
      University of California at Los Angeles (UCLA )
    Dec 1, 2022

    Metastatic Solid Tumor Trial ([18F]AlF-RESCA-IL2 PET scan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • [18F]AlF-RESCA-IL2 PET scan
    • (no location specified)
    Jul 20, 2022

    COVID-19, Lymphocytopenia Trial in United Kingdom (Interleukin-7, Placebos)

    Terminated
    • COVID-19
    • Lymphocytopenia
    • Birmingham, United Kingdom
    • +12 more
    Mar 30, 2022

    Systemic Lupus Erythematosus Trial in Beijing (Telitacicept, Interleukin-2)

    Recruiting
    • Systemic Lupus Erythematosus
    • Beijing, Beijing, China
      Department of Rheumatology and Immunology, Peking University Peo
    Apr 26, 2022

    Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

    Active, not recruiting
    • Human Papillomavirus-16 Positive
    • +20 more
    • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
    • Durvalumab
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 11, 2022

    Tumor Necrosis Factor-alpha and Interleukin-18 Levels in

    Completed
    • Periodontal Diseases
    • ELISA
    • Aydin, Turkey
      Sultan KELES
    Nov 27, 2019

    Psoriatic Arthritis Trial in Germany, Netherlands, United Kingdom (AIN457A, Other)

    Completed
    Has Results
    • Psoriatic Arthritis
    • AIN457A
    • Other
    • Hamburg, Germany
    • +5 more
    May 26, 2021

    High Risk Neuroblastoma Trial in United States (biological, other, drug)

    Completed
    Has Results
    • High Risk Neuroblastoma
    • Aldesleukin
    • +4 more
    • Loma Linda, California
    • +31 more
    Jul 30, 2021

    Hepatitis C Trial (interleukin IL-1beta and interleukin IL-18)

    Unknown status
    • Hepatitis C
    • interleukin IL-1beta and interleukin IL-18
    • (no location specified)
    Jan 24, 2020

    HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Plasma Cell Myeloma Trial in Los Angeles

    Withdrawn
    • HLA-A*0201 Positive Cells Present
    • +3 more
    • 18F-FHBG
    • +10 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jul 22, 2020

    Melanoma (Skin) Trial in Madison (hu14.18-IL2 fusion protein)

    Completed
    • Melanoma (Skin)
    • hu14.18-IL2 fusion protein
    • Madison, Wisconsin
      University of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
    Nov 15, 2019

    Trauma, Brain Trial in Tanta (Amantadine (100mg) as add on therapy., Placebo)

    Completed
    • Trauma, Brain
    • Amantadine (100mg) as add on therapy.
    • Placebo
    • Tanta, Elgarbia, Egypt
      Tanta University Hospital
    Dec 20, 2021

    Inflammatory and Anti-Inflammatory Gene Expressions in Liver

    Active, not recruiting
    • Liver Transplant; Complications
    • +3 more
    • Molecular Immunology , gene expressions
    • Malatya, Turkey
      İnönü University
    May 2, 2023

    Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Soft Palate Trial in Worldwide (biological, drug,

    Completed
    Has Results
    • Squamous Cell Carcinoma of the Oral Cavity
    • Squamous Cell Carcinoma of the Soft Palate
    • LI
    • +6 more
    • Springfield, Illinois
    • +101 more
    Aug 17, 2022

    CLDN18.2-positive Gastric Adenocarcinoma, CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction, CLDN18.2-positive

    Completed
    • CLDN18.2-positive Gastric Adenocarcinoma
    • +2 more
    • Frankfurt, Hessen, Germany
    • +8 more
    Oct 16, 2019

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

    Not yet recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +3 more
    • Biospecimen Collection
    • +8 more
    • Kansas City, Kansas
      University of Kansas Cancer Center
    Nov 27, 2023

    Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide

    Active, not recruiting
    Has Results
    • Localized Resectable Neuroblastoma
    • +5 more
    • Aldesleukin
    • +6 more
    • Birmingham, Alabama
    • +196 more
    Dec 30, 2022

    Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

    Active, not recruiting
    Has Results
    • Kidney Cancer
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jun 21, 2022

    Critical Care, Respiration, Artificial, Sedation Trial in Oviedo (Music Therapy)

    Recruiting
    • Critical Care
    • +2 more
    • Music Therapy
    • Oviedo, Asturias, Spain
      Hospital Universitario Central de Asturias
    Nov 1, 2023

    Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Histamine Dihydrochloride (HDC)
    • Interleukin-2 (IL-2)
    • (no location specified)
    Mar 31, 2023

    Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

    Recruiting
    • Melanoma Stage III
    • +2 more
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 6, 2022